Liposome delivery systems for the treatment of Alzheimer’s disease

Liposome delivery systems for the treatment of Alzheimer’s disease

Callum Ross, Mark Taylor, Nigel Fullwood, David Allsop Division of Biomedical and Life Sciences, Faculty of Health and Medicine, Lancaster University, Lancaster LA1 4YQ, UK Abstract: Alzheimer’s disease (AD) will affect around 115 million people worldwide by the year 2050. It is...

Full description

Bibliographic Details
Main Authors:	Ross C, Taylor M, Fullwood N, Allsop D
Format:	Article
Language:	English
Published:	Dove Medical Press 2018-12-01
Series:	International Journal of Nanomedicine
Subjects:	amyloid blood brain barrier cell penetrating peptides neurofibrillary tangles senile plaques Tau
Online Access:	https://www.dovepress.com/liposome-delivery-systems-for-the-treatment-of-alzheimers-disease-peer-reviewed-article-IJN

Similar Items

Genetic and non-genetic factors responsible for mitochondrial failure and Alzheimer’s disease
by: Gao Kuo, et al.
Published: (2014-01-01)

Intravenous Injection of PHF-Tau Proteins From Alzheimer Brain Exacerbates Neuroinflammation, Amyloid Beta, and Tau Pathologies in 5XFAD Transgenic Mice
by: Sarah Houben, et al.
Published: (2020-07-01)

Aβ plaques
by: Lary C Walker
Published: (2020-10-01)

Amyloid beta 1-42 and phoshorylated tau threonin 231 in brains of aged cynomolgus monkeys (Macaca fascicularis)
by: Huda Shalahudin Darusman, et al.
Published: (2014-11-01)

The neuropathological diagnosis of Alzheimer’s disease
by: Michael A. DeTure, et al.
Published: (2019-08-01)

Targeting Autophagy for the Treatment of Alzheimer’s Disease: Challenges and Opportunities
by: Jie Liu, et al.
Published: (2019-08-01)

Peptides as Potential Therapeutics for Alzheimer’s Disease
by: Samo Ribarič
Published: (2018-01-01)

Insights into Alzheimer disease pathogenesis from studies in transgenic animal models
by: Evelin L. Schaeffer, et al.
Published: (2011-01-01)

Does taking statins affect the pathological burden in autopsy-confirmed Alzheimer’s dementia?
by: Jana Crum, et al.
Published: (2018-10-01)

Bridging the Gap between Alzheimer’s Disease and Alzheimer’s-like Diseases in Animals
by: Anita Gołaszewska, et al.
Published: (2019-04-01)

Emerging Signal Regulating Potential of Genistein Against Alzheimer’s Disease: A Promising Molecule of Interest
by: Md. Sahab Uddin, et al.
Published: (2019-09-01)

Vitamin E therapy prevents the accumulation of congophilic amyloid plaques and neurofibrillary tangles in the hippocampus in a rat model of Alzheimer’s disease
by: Mehrdad Jahanshahi, et al.
Published: (2020-01-01)

Deciphering the Astrocyte Reaction in Alzheimer’s Disease
by: Beatriz G. Perez-Nievas, et al.
Published: (2018-04-01)

Progress of RAGE Molecular Imaging in Alzheimer’s Disease
by: Yanyan Kong, et al.
Published: (2020-08-01)

Potential therapeutic roles of retinoids for prevention of neuroinflammation and neurodegeneration in Alzheimer’s disease
by: Bhaskar C Das, et al.
Published: (2019-01-01)

Fyn depletion ameliorates tauP301L-induced neuropathology
by: Guanghao Liu, et al.
Published: (2020-07-01)

Molecular Biomarkers for Diagnosis & Therapies of Alzheimer’s Disease
by: Pravin D Potdar, et al.
Published: (2016-11-01)

Detection of hyperphosphorylated tau protein and α-synuclein in spinal cord of patients with Alzheimer’s disease
by: Guo YJ, et al.
Published: (2016-02-01)

Alzheimer's disease pathology in aged chimpanzees
by: Edler, Melissa K.
Published: (2016)

Alzheimer’s Disease Animal Models: Elucidation of Biomarkers and Therapeutic Approaches for Cognitive Impairment
by: Tsuyoshi Nakai, et al.
Published: (2021-05-01)

Insulin Resistance at the Crossroad of Alzheimer Disease Pathology: A Review
by: Jorge Berlanga-Acosta, et al.
Published: (2020-11-01)

Alzheimer’s disease: A Threat to mankind
by: Poorti Pandey, et al.
Published: (2011-12-01)

The lipid phosphatase Synaptojanin 1 undergoes a significant alteration in expression and solubility and is associated with brain lesions in Alzheimer’s disease
by: Kunie Ando, et al.
Published: (2020-06-01)

The effects of bioactive components from the rhizome of Salvia miltiorrhiza (Danshen) on the characteristics of Alzheimer’s disease
by: Cheong-Meng Chong, et al.
Published: (2019-05-01)

de novo MAPT mutation G335A causes severe brain atrophy, 3R and 4R PHF-tau pathology and early onset frontotemporal dementia
by: Kunie Ando, et al.
Published: (2020-06-01)

Alzheimer Disease Pathogenesis: Insights From Molecular and Cellular Biology Studies of Oligomeric Aβ and Tau Species
by: Xu-Qiao Chen, et al.
Published: (2019-06-01)

MicroRNAs in Alzheimer’s Disease
by: Mengli Wang, et al.
Published: (2019-03-01)

Research Progress in the Pathogenesis of Alzheimer's Disease
by: Yi-Gang Chen
Published: (2018-01-01)

Differentiating Alzheimer disease-associated aggregates with small molecules
by: Nicolette S. Honson, et al.
Published: (2007-12-01)

Alois alzheimer
by: Padmapriya Gorjilli
Published: (2015-01-01)

Dissecting the role of non-coding RNAs in the accumulation of amyloid and tau neuropathologies in Alzheimer’s disease
by: Ellis Patrick, et al.
Published: (2017-07-01)

The relationship between truncation and phosphorylation at the C-terminus of tau protein in the paired helical filaments of Alzheimer's disease.
by: Paola eFlores-Rodríguez, et al.
Published: (2015-02-01)

Toxic tau: structural origins of tau aggregation in Alzheimer's disease
by: Abdullah Al Mamun, et al.
Published: (2020-01-01)

Periodontitis and Alzheimer’s Disease: A Possible Comorbidity between Oral Chronic Inflammatory Condition and Neuroinflammation
by: Francisco B. Teixeira, et al.
Published: (2017-10-01)

New piperazine multi-effect drugs prevent neurofibrillary degeneration and amyloid deposition, and preserve memory in animal models of Alzheimer's disease
by: Nicolas Sergeant, et al.
Published: (2019-09-01)

Caspase-9 Activation and Caspase Cleavage of tau in the Alzheimer's Disease Brain
by: Troy T. Rohn, et al.
Published: (2002-11-01)

The Neuroanatomy of the Reticular Nucleus Locus Coeruleus in Alzheimer’s Disease
by: Filippo S. Giorgi, et al.
Published: (2017-09-01)

Synthesis, Computational Pharmacokinetics Report, Conceptual DFT-Based Calculations and Anti-Acetylcholinesterase Activity of Hydroxyapatite Nanoparticles Derived From Acorus Calamus Plant Extract
by: Sushma Pradeep, et al.
Published: (2021-10-01)

In vivo detection of tau fibrils and amyloid β aggregates with luminescent conjugated oligothiophenes and multiphoton microscopy
by: Maria Calvo-Rodriguez, et al.
Published: (2019-11-01)

Inhibition of the Self-Assembly of Aβ and of Tau by Polyphenols: Mechanistic Studies
by: Qiuchen Zheng, et al.
Published: (2019-06-01)